- Home
- CBLL
as 12-17-2024 4:00pm EST
Stocks
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SUNNYVALE |
| Market Cap: | 1.0B | IPO Year: | 2024 |
| Target Price: | $33.25 | AVG Volume (30 days): | 167.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $23.00 - $32.75 | Next Earning Date: | 11-12-2024 |
| Revenue: | $60,041,000 | Revenue Growth: | 131.62% |
| Revenue Growth (this year): | 44.86% | Revenue Growth (next year): | 26.56% |
Latest CeriBell Inc. Common Stock News
CBLL Breaking Stock News: Dive into CBLL Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing
FastCompany
a month ago
Meet the biophysicist whose seizure-detection company is using AI to get a better read on people’s brains
TipRanks
a month ago
Ceribell, Inc. Reports Strong Q3 2024 Growth
GlobeNewswire
a month ago
Ceribell Reports Third Quarter 2024 Financial Results
MT Newswires
a month ago
CeriBell Receives Authorization from Department of Veterans Affairs for EEG Technology
GlobeNewswire
a month ago
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs
GlobeNewswire
a month ago
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
TipRanks
a month ago
Ceribell initiated with a Buy at BofA on ‘differentiated AI algorithm’
Compare CBLL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CBLL CeriBell Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.